Prescription Drug Price Relief Act of 2025

# Prescription Drug Price Relief Act of 2025 Summary **What the Bill Does:** The Prescription Drug Price Relief Act of 2025 aims to address high prescription drug prices in the United States. While specific details aren't provided in the basic information available, bills with this title typically focus on allowing Medicare to negotiate drug prices directly with pharmaceutical companies and/or implementing price caps on prescription medications. The bill would primarily affect patients who struggle to afford medications, pharmaceutical companies, and Medicare—the federal health program for seniors and some disabled individuals. **Current Status:** As of now, the bill (HR 3546) remains in committee, meaning it has been introduced but has not yet been voted on by the full House of Representatives.

The bill was sponsored by Representative Ro Khanna (D-California). **Note:** For a complete understanding of the specific provisions, you would need to review the full bill text, as the summary here covers only general information. Congressional bills in this policy area often generate debate between those who prioritize patient affordability and those concerned about impacts on drug development and innovation.